Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Patients’ quality of life during active cancer treatment: a qualitative study

Authors: Jordan Sibeoni, Camille Picard, Massimiliano Orri, Mathilde Labey, Guilhem Bousquet, Laurence Verneuil, Anne Revah-Levy

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Patients’ quality of life has become a major objective of care in oncology. At the same time, it has become the object of increasing interest by researchers, working with both quantitative and qualitative methods. Progress in oncology has enabled more patients to survive longer, so that cancer is increasingly often a chronic disease that requires long-term treatment that can have negative effects on patients’ quality of daily life. Nonetheless, no qualitative study has explored what patients report affects their quality of daily life during the treatment period. This study is intended to fill this gap.

Methods

We conducted a multicenter qualitative study based on 30 semi-structured interviews. Participants, purposively selected until data saturation, had diverse types of cancer and had started treatment at least 6 months before interview. Data were examined by thematic analysis.

Results

Our analysis found two themes: (1) what negatively affected for patient’s quality of daily life during the treatment period, a question to which patients responded by talking only about the side effects of treatment; and (2) what positively affected their quality of daily life during the treatment period with three sub-themes: (i) The interest in having —investing in — a support object that can be defined as an object, a relationship or an activity particularly invested by the patients which makes them feel good and makes the cancer and its treatment bearable, (ii)The subjective perception of the efficacy of the antitumor treatment and (iii) the positive effects of relationships, with friends and family, and also with their physician.

Conclusions

Patients must be involved in their care if they are to be able to bear their course of treatment and find ways to endure the difficult experience of cancer care. The support object represents an important therapeutic lever that can be used by their oncologists. They should be interested in their support objects, in order to support the patients in this investment and to help them to maintain it throughout the health care pathway. Furthermore, showing interest in this topic, important to the patient, could improve the physician-patient relation without using up very much of the physician’s time.
Literature
1.
go back to reference Sosnowski R, Kulpa M, Ziętalewicz U, Wolski JK, Nowakowski R, Bakuła R, Demkow T. Basic issues concerning health-related quality of life. Cent Eur J Urol. 2017;70(2). Sosnowski R, Kulpa M, Ziętalewicz U, Wolski JK, Nowakowski R, Bakuła R, Demkow T. Basic issues concerning health-related quality of life. Cent Eur J Urol. 2017;70(2).
2.
go back to reference Bennett BM, Wells JR, Panter C, Yuan Y, Penrod JR. The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature. Frontiers in Pharmacology. 2017;15(8). Bennett BM, Wells JR, Panter C, Yuan Y, Penrod JR. The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature. Frontiers in Pharmacology. 2017;15(8).
3.
go back to reference Korol EE, Wang S, Johnston K, Ravandi-Kashani F, Levis M, van Nooten F. Health-related quality of life of patients with acute myeloid leukemia: a systematic literature review. Oncol Ther. 2017;5(1):1–16.CrossRef Korol EE, Wang S, Johnston K, Ravandi-Kashani F, Levis M, van Nooten F. Health-related quality of life of patients with acute myeloid leukemia: a systematic literature review. Oncol Ther. 2017;5(1):1–16.CrossRef
4.
go back to reference Walter T. Maintaining quality of life for patients with neuroendocrine tumours. Lancet Oncol. 2017;18(10):1299–300.CrossRef Walter T. Maintaining quality of life for patients with neuroendocrine tumours. Lancet Oncol. 2017;18(10):1299–300.CrossRef
5.
go back to reference Ganguli A, Wiegand P, Gao X, Carter JA, Botteman MF, Ray S. The impact of second-line agents on patients’ health-related quality of life in the treatment for non-small cell lung cancer: a systematic review. Qual Life Res. 2013;22(5):1015–26.CrossRef Ganguli A, Wiegand P, Gao X, Carter JA, Botteman MF, Ray S. The impact of second-line agents on patients’ health-related quality of life in the treatment for non-small cell lung cancer: a systematic review. Qual Life Res. 2013;22(5):1015–26.CrossRef
6.
go back to reference Mutsaers A, Greenspoon J, Walker-Dilks C, Swaminath A. Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer. Radiat Oncol. 2017;12(1). Mutsaers A, Greenspoon J, Walker-Dilks C, Swaminath A. Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer. Radiat Oncol. 2017;12(1).
7.
go back to reference Siyam T, Ross S, Campbell S, Eurich DT, Yuksel N. The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review. BMC Womens Health. 2017;17(1). Siyam T, Ross S, Campbell S, Eurich DT, Yuksel N. The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review. BMC Womens Health. 2017;17(1).
8.
go back to reference RETURN TO BREAST Collaborative group, D’Egidio V, Sestili C, Mancino M, Sciarra I, Cocchiara R, et al. Counseling interventions delivered in women with breast cancer to improve health-related quality of life: a systematic review. Qual Life Res. 2017;26(10):2573–92.CrossRef RETURN TO BREAST Collaborative group, D’Egidio V, Sestili C, Mancino M, Sciarra I, Cocchiara R, et al. Counseling interventions delivered in women with breast cancer to improve health-related quality of life: a systematic review. Qual Life Res. 2017;26(10):2573–92.CrossRef
9.
go back to reference McLachlan S-A, Allenby A, Matthews J, Wirth A, Kissane D, Bishop M, et al. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with Cancer. J Clin Oncol. 2001;19(21):4117–25.CrossRef McLachlan S-A, Allenby A, Matthews J, Wirth A, Kissane D, Bishop M, et al. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with Cancer. J Clin Oncol. 2001;19(21):4117–25.CrossRef
10.
go back to reference Gonzalez-saenz de Tejada M, Bilbao A, Baré M, Briones E, Sarasqueta C, Quintana JM, et al. Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients: social support, functional status, HRQoL, and distress in CRC. Psycho-Oncology. 2017;26(9):1263–9.CrossRef Gonzalez-saenz de Tejada M, Bilbao A, Baré M, Briones E, Sarasqueta C, Quintana JM, et al. Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients: social support, functional status, HRQoL, and distress in CRC. Psycho-Oncology. 2017;26(9):1263–9.CrossRef
12.
go back to reference Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.CrossRef Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.CrossRef
13.
go back to reference Shao Z, Zhu T, Zhang P, Wen Q, Li D, Wang S. Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer. Health Qual Life Outcomes. 2017;15(1). Shao Z, Zhu T, Zhang P, Wen Q, Li D, Wang S. Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer. Health Qual Life Outcomes. 2017;15(1).
14.
go back to reference Faguet GB. Quality end-of-life cancer care: an overdue imperative. Crit Rev Oncol Hematol. 2016;108:69–72.CrossRef Faguet GB. Quality end-of-life cancer care: an overdue imperative. Crit Rev Oncol Hematol. 2016;108:69–72.CrossRef
15.
go back to reference Park S-A, Chung SH, Lee Y. Factors influencing the quality of life of patients with advanced cancer. Appl Nurs Res. 2017;33:108–12.CrossRef Park S-A, Chung SH, Lee Y. Factors influencing the quality of life of patients with advanced cancer. Appl Nurs Res. 2017;33:108–12.CrossRef
16.
go back to reference Høxbroe Michaelsen S, Grønhøj C, Høxbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91–102.CrossRef Høxbroe Michaelsen S, Grønhøj C, Høxbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91–102.CrossRef
18.
go back to reference Kaplan RM, Ries AL. Quality of life: concept and definition. J Chron Obstruct Pulmon Dis. 2007;4(3):263–71.CrossRef Kaplan RM, Ries AL. Quality of life: concept and definition. J Chron Obstruct Pulmon Dis. 2007;4(3):263–71.CrossRef
19.
go back to reference Morse JM. Qualitative health research: creating a new discipline. Walnut Creek: Left Coast Press; 2012. p. 176. Morse JM. Qualitative health research: creating a new discipline. Walnut Creek: Left Coast Press; 2012. p. 176.
20.
go back to reference Jassim GA, Whitford DL. Understanding the experiences and quality of life issues of Bahraini women with breast cancer. Soc Sci Med. 2014;107:189–95.CrossRef Jassim GA, Whitford DL. Understanding the experiences and quality of life issues of Bahraini women with breast cancer. Soc Sci Med. 2014;107:189–95.CrossRef
21.
go back to reference Burke S, Wurz A, Bradshaw A, Saunders S, West MA, Brunet J. Physical activity and quality of life in Cancer survivors: a meta-synthesis of qualitative research. Cancers. 2017;9(6):53.CrossRef Burke S, Wurz A, Bradshaw A, Saunders S, West MA, Brunet J. Physical activity and quality of life in Cancer survivors: a meta-synthesis of qualitative research. Cancers. 2017;9(6):53.CrossRef
22.
go back to reference Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(S11):2577–92.CrossRef Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(S11):2577–92.CrossRef
23.
go back to reference Patton MQ. Purposeful Sampling. Qualitative research & evaluation methods. 3rd ed. Thousand Oaks: Sage; 2002. p. 230–48. Patton MQ. Purposeful Sampling. Qualitative research & evaluation methods. 3rd ed. Thousand Oaks: Sage; 2002. p. 230–48.
24.
go back to reference Dey I. Grounding grounded theory: guidelines for qualitative inquiry. San Diego: Academic Press; 1999.CrossRef Dey I. Grounding grounded theory: guidelines for qualitative inquiry. San Diego: Academic Press; 1999.CrossRef
25.
go back to reference Braun V, Clarke V, Terry G. Chapter 7 thematic analysis. In: Qualitative research in clinical and Health Psychology- Poul Rohleder, Antonia C Lyons Palgrave Macmillan,. Palgrave Macmillan; 2014. Braun V, Clarke V, Terry G. Chapter 7 thematic analysis. In: Qualitative research in clinical and Health Psychology- Poul Rohleder, Antonia C Lyons Palgrave Macmillan,. Palgrave Macmillan; 2014.
26.
go back to reference O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–51.CrossRef O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–51.CrossRef
27.
go back to reference Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psycho-Oncology 2007; 1;16(3):181–188. Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psycho-Oncology 2007; 1;16(3):181–188.
28.
go back to reference Zhen R, Quan L, Zhou X. Co-occurring patterns of post-traumatic stress disorder and depression among flood victims: a latent profile analysis. J Health Psychol. 2018:135910531876350. Zhen R, Quan L, Zhou X. Co-occurring patterns of post-traumatic stress disorder and depression among flood victims: a latent profile analysis. J Health Psychol. 2018:135910531876350.
29.
go back to reference Abbey G, Thompson SBN, Hickish T, Heathcote D. A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder. Psycho-Oncology 2015; 1;24(4):371–381.CrossRef Abbey G, Thompson SBN, Hickish T, Heathcote D. A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder. Psycho-Oncology 2015; 1;24(4):371–381.CrossRef
30.
go back to reference Larsen SE, Berenbaum H. Did the DSM-5 improve the traumatic stressor criterion?: association of DSM-IV and DSM-5 criterion a with posttraumatic stress disorder symptoms. Psychopathology. 2017;50(6):373–8.CrossRef Larsen SE, Berenbaum H. Did the DSM-5 improve the traumatic stressor criterion?: association of DSM-IV and DSM-5 criterion a with posttraumatic stress disorder symptoms. Psychopathology. 2017;50(6):373–8.CrossRef
31.
go back to reference Koedoot C g, de Haes J, Heisterkamp S, Bakker P, de Graeff A, de Haan R. Palliative chemotherapy or watchful waiting? A vignettes study among oncologists. JCO 2002 1;20(17):3658–3664.CrossRef Koedoot C g, de Haes J, Heisterkamp S, Bakker P, de Graeff A, de Haan R. Palliative chemotherapy or watchful waiting? A vignettes study among oncologists. JCO 2002 1;20(17):3658–3664.CrossRef
32.
go back to reference Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology 2008; 1;17(4):317–328.CrossRef Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology 2008; 1;17(4):317–328.CrossRef
33.
go back to reference Rosen AC, Case EC, Dusza SW, Balagula Y, Gordon J, West DP, et al. Impact of dermatologic adverse events on quality of life in 283 Cancer patients: a questionnaire study in a dermatology referral clinic. Am J Clin Dermatol 2013 1;14(4):327–333.CrossRef Rosen AC, Case EC, Dusza SW, Balagula Y, Gordon J, West DP, et al. Impact of dermatologic adverse events on quality of life in 283 Cancer patients: a questionnaire study in a dermatology referral clinic. Am J Clin Dermatol 2013 1;14(4):327–333.CrossRef
34.
go back to reference Hershman D, Calhoun E, Zapert K, Wade S, Malin J, Barron R. Patients’ perceptions of physician-patient discussions and adverse events with Cancer therapy: patient perceptions of adverse events with chemotherapy. Arch Drug Inf. 2008;1(2):70–8.CrossRef Hershman D, Calhoun E, Zapert K, Wade S, Malin J, Barron R. Patients’ perceptions of physician-patient discussions and adverse events with Cancer therapy: patient perceptions of adverse events with chemotherapy. Arch Drug Inf. 2008;1(2):70–8.CrossRef
35.
go back to reference Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of Cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 2008 10;26(23):3860–3866. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of Cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 2008 10;26(23):3860–3866.
36.
go back to reference Song Y, Lv X, Liu J, Huang D, Hong J, Wang W, et al. Experience of nursing support from the perspective of patients with cancer in mainland China: nursing support for patients with cancer. Nurs Health Sci. 2016;18(4):510–8.CrossRef Song Y, Lv X, Liu J, Huang D, Hong J, Wang W, et al. Experience of nursing support from the perspective of patients with cancer in mainland China: nursing support for patients with cancer. Nurs Health Sci. 2016;18(4):510–8.CrossRef
37.
go back to reference Wei C, Nengliang Y, Yan W, Qiong F, Yuan C. The patient-provider discordance in patients’ needs assessment: a qualitative study in breast cancer patients receiving oral chemotherapy. J Clin Nurs. 2017;26(1–2):125–32.CrossRef Wei C, Nengliang Y, Yan W, Qiong F, Yuan C. The patient-provider discordance in patients’ needs assessment: a qualitative study in breast cancer patients receiving oral chemotherapy. J Clin Nurs. 2017;26(1–2):125–32.CrossRef
38.
go back to reference Best M, Butow P, Olver I. Doctors discussing religion and spirituality: a systematic literature review. Palliat Med 2016; 1;30(4):327–337.CrossRef Best M, Butow P, Olver I. Doctors discussing religion and spirituality: a systematic literature review. Palliat Med 2016; 1;30(4):327–337.CrossRef
39.
go back to reference Williams JA, Meltzer D, Arora V, Chung G, Curlin FA. Attention to inpatients’ religious and spiritual concerns: predictors and association with patient satisfaction. J Gen Intern Med. 2011;26(11):1265–71.CrossRef Williams JA, Meltzer D, Arora V, Chung G, Curlin FA. Attention to inpatients’ religious and spiritual concerns: predictors and association with patient satisfaction. J Gen Intern Med. 2011;26(11):1265–71.CrossRef
40.
go back to reference Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult Cancer patients: achievements and challenges. CA Cancer J Clin. 2008;58(4):214–30.CrossRef Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult Cancer patients: achievements and challenges. CA Cancer J Clin. 2008;58(4):214–30.CrossRef
41.
go back to reference Kehl KL, Landrum MB, Arora NK, Ganz PA, Van Ryn M, Mack JW, Keating NL. Association of actual and preferred decision roles with patient-reported quality of care: shared decision making in cancer care. JAMA Oncol. 2015;1(1):50–8.CrossRef Kehl KL, Landrum MB, Arora NK, Ganz PA, Van Ryn M, Mack JW, Keating NL. Association of actual and preferred decision roles with patient-reported quality of care: shared decision making in cancer care. JAMA Oncol. 2015;1(1):50–8.CrossRef
42.
go back to reference Hanlon P, Daines L, Campbell C, McKinstry B, Weller D, Pinnock H. Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res. 2017;19(5). Hanlon P, Daines L, Campbell C, McKinstry B, Weller D, Pinnock H. Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res. 2017;19(5).
Metadata
Title
Patients’ quality of life during active cancer treatment: a qualitative study
Authors
Jordan Sibeoni
Camille Picard
Massimiliano Orri
Mathilde Labey
Guilhem Bousquet
Laurence Verneuil
Anne Revah-Levy
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4868-6

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine